Upregulation of SLC25A29 may increase the concentration of arginine in the mitochondrial matrix, which is then utilized by mitochondrial arginase 2 to produce ornithine; the latter serves as a precursor for polyamine synthesis, metabolites known for their tumor-promoting properties. This evidence concerns the gene SLC25A29 and neoplasm.